Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

 (NOVN)

43
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on NOVARTIS AG
03/13 NOVARTIS AG: Novartis data at AAN reinforces commitment to address high unmet m..
03/12DJPharma Groups Set Up Fund to Help Interpol Fight Fake Drugs
03/10DJNOVARTIS AG: Former Novartis Chairman Vasella Moving to US - Report
03/07 Merck KGaA sees profit boost from cost costs and TVs
03/06 Expectations low for UBS bankers awaiting bonus awards
03/05DJRoche Chairman Humer To Stand Down; Successor Not Yet Known
03/04DJEUROPE MARKETS: Europe Stocks Drop With China, Sequester In Focus
03/04DJEUROPE MARKETS: Europe Stocks Drop With China, Sequester In Focus
03/04DJEUROPE MARKETS: Europe Stocks Drop With China, Sequester In Focus
03/03 Swiss back executive pay curbs in referendum
03/03 Swiss back executive pay curbs in referendum
03/01 NOVARTIS AG: Novartis receives EU approval for Ilaris® in patients suffering ac..
02/28DJEndo Health Swings to Surprise 4th-Quarter Loss Amid Big Write-Down
02/28DJNovartis Launches Effort To Fight Heart Disease In Zambia
02/28 NOVARTIS AG: Novartis collaboration aims to eliminate rheumatic heart disease (..
02/26 NOVARTIS AG: ex-dividend day for annual dividend
02/25DJPfizer Plans More Alliances in China
02/24 NOVARTIS AG: Novartis reports Phase III data showing omalizumab improved itch i..
02/22 NOVARTIS AG: Shareholders approve all resolutions proposed by Novartis Board of..
02/19 Novartis scraps $78 million pay for outgoing chairman Vasella
02/19DJNOVARTIS AG: Novartis Cancels Chairman's Exit Pay
02/19DJNOVARTIS AG: Novartis Cancels Chairman's Exit Pay
02/19 NOVARTIS AG: Novartis Board of Directors and Dr. Daniel Vasella agree to cancel..
02/19DJNOVARTIS AG: Novartis verzichtet auf millionenschweres Abfindungspaket für Vase..
02/19 NOVARTIS AG: Novartis scraps $78 million pay for outgoing chairman Vasella
02/19DJNOVARTIS AG: Novartis Cancels CHF72Mn Compensation Package for Chairman Vasella
02/17 NOVARTIS AG: Novartis golden handshake angers shareholders, politicians
02/16 NOVARTIS AG: Novartis drug Zortress® is first in over a decade approved by FDA ..
02/13DJJapan GDP Shrinks for Third-Straight Quarter
02/12 Drugmakers eye Africa's middle classes as next growth market
02/12DJGlaxoSmithKline, Others Weighing $3 Billion-$4 Billion Deal For Brazilian Dru..
02/05DJProtalix Confirms It's Considering Options; Shares Surge
01/31DJNOVARTIS AG: Novartis Recalls Triaminic, Theraflu Syrups
01/31DJNOVARTIS AG: Novartis Recalls Triaminic, Theraflu Syrups Over Bottle Seal Probl..
01/31DJNOVARTIS AG: Novartis Recalls Triaminic, Theraflu Syrups Over Bottle Seal Probl..
01/31DJNOVARTIS AG: Novartis Recalls Triaminic, Theraflu Syrups Over Seal Problem
01/31DJJ&J, Novartis Get EU Antitrust Complaint
01/31DJEU Sends Formal Antitrust Complaint to J&J, Novartis
01/25DJNOVARTIS AG: FDA Approves New Use for Novartis Cancer Drug Gleevec in Children
01/25DJNOVARTIS AG: Novartis CEO : Alcon Probe Was from 2005 Event -Fox Business
01/24DJNOVARTIS AG: Novartis U.S. Unit Subpoenaed in Probe
01/24DJNOVARTIS AG: EMA : Novartis Europharm Pulls Ruvise Marketing Authorization Appl..
01/23DJNOVARTIS AG: Correction to Story on Wider FDA Approval for Novartis Drug
01/23 NOVARTIS AG: Novartis drug Exjade® first treatment approved by FDA for chronic ..
01/23DJNOVARTIS AG: Novartis Gains FDA Approval For Wider Use of Drug to Treat Iron Ov..
01/23DJNOVARTIS: U.S. Probing Export of Alcon Products to Iran, Other Trade-Sanction C..
01/23DJEUROPE MARKETS: Europe Stocks Rise Ahead Of U.S. Debt Vote
01/23DJEUROPE MARKETS: Europe Stocks Waver With U.S. Debt Vote In Sight
01/23DJEUROPE MARKETS: Europe Stocks Waver With U.S. Debt Vote In Sight
01/23DJBuilder of Novartis Is Stepping Down
01/23DJEUROPE MARKETS: Europe Stocks Waver With U.S. Debt In Sight
01/23DJNOVARTIS AG: Novartis Expects Return to Growth Next Year
01/23DJNOVARTIS AG: Novartis Wary on 2013, Expects to Return to Growth Next Year
01/23DJBayer's Reinhardt to Leave Co With Aim of Joining Novartis
01/23 NOVARTIS AG: Novartis delivers strong innovation in 2012, offsetting patent exp..
01/22 NOVARTIS AG: Novartis receives EU approval for Bexsero®, first vaccine to preve..
01/18DJNOVARTIS AG: EARNINGS FORECAST TABLE : Novartis 4Q 2012
01/18NOVARTIS AG: quaterly earnings release
01/18 NOVARTIS AG: Novartis receives positive CHMP opinion for Ilaris® to treat patie..
01/18 NOVARTIS AG: Jetrea(TM) receives positive CHMP opinion, would become the first ..
01/17 NOVARTIS AG: Novartis makes progress in the fight to eliminate leprosy worldwid..
01/16DJEUROPE MARKETS: Europe Shares Struggle On Growth Fears
01/16DJEUROPE MARKETS: Europe Stocks Slip On Growth Fears
01/16DJEUROPE MARKETS: Europe Stocks Slip On Worries Over Euro Strength
01/14DJPfizer, Others Eye Strides Arcolab's Agila Unit -Bloomberg
01/14 NOVARTIS AG: Pivotal study in The Lancet shows potential of Novartis vaccine Be..
01/11DJEUROPE MARKETS: Europe Stocks Waver With Japan, China In Focus
01/11DJEUROPE MARKETS: Europe Stocks Waver With Japan, China In Focus
01/10 NOVARTIS AG: Phase III data in The Lancet show significant benefit of Novartis ..
01/08DJChina Sets Price Restrictions on Some Drugs
01/08DJAffymetrix to Restructure; Financial Chief to Retire
01/08DJNOVARTIS AG: Novartis CEO : Acquisitions This Year Likely to Be in Range of $2 ..
01/08DJMARKET COMMENT: Zurich Stocks Close Slightly Higher
01/08DJBiogen Needs Strong BG-12 Launch to Maintain Momentum
01/03DJU.K.'s NICE Backs Novartis Eye Drug for New Use
Prev.1   2  3  4  5  6Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
Novartis AG : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.